Show simple item record

dc.contributor.authorMaciej-Hulme, Marissa L.; orcid: 0000-0001-5615-4197; email: marissa.maciej-hulme@radboudumc.nl
dc.contributor.authorDubaissi, Eamon; email: eamon.dubaissi@manchester.ac.uk
dc.contributor.authorShao, Chun; email: Chun.Shao@bms.com
dc.contributor.authorZaia, Joseph; orcid: 0000-0001-9497-8701; email: jzaia@bu.edu
dc.contributor.authorAmaya, Enrique; orcid: 0000-0002-1805-8548; email: enrique.amaya@manchester.ac.uk
dc.contributor.authorFlitsch, Sabine L.; email: Sabine.Flitsch@manchester.ac.uk
dc.contributor.authorMerry, Catherine L. R.; orcid: 0000-0002-3490-2809; email: cathy.merry@nottingham.ac.uk
dc.date.accessioned2021-07-01T02:12:29Z
dc.date.available2021-07-01T02:12:29Z
dc.date.issued2021-06-29
dc.identifierhttps://chesterrep.openrepository.com/bitstream/handle/10034/625104/ijms-22-06988-v2.pdf?sequence=2
dc.identifierhttps://chesterrep.openrepository.com/bitstream/handle/10034/625104/additional-files.zip?sequence=3
dc.identifierhttps://chesterrep.openrepository.com/bitstream/handle/10034/625104/ijms-22-06988.xml?sequence=4
dc.identifier.citationInternational Journal of Molecular Sciences, volume 22, issue 13, page e6988
dc.identifier.urihttp://hdl.handle.net/10034/625104
dc.descriptionFrom MDPI via Jisc Publications Router
dc.descriptionHistory: accepted 2021-06-19, pub-electronic 2021-06-29
dc.descriptionPublication status: Published
dc.descriptionFunder: Biotechnology and Biological Sciences Research Council; Grant(s): 978724
dc.descriptionFunder: Medical Research Council; Grant(s): MR/L007525/1
dc.description.abstractThe glycosaminoglycan, heparan sulphate (HS), orchestrates many developmental processes. Yet its biological role has not yet fully been elucidated. Small molecule chemical inhibitors can be used to perturb HS function and these compounds provide cheap alternatives to genetic manipulation methods. However, existing chemical inhibition methods for HS also interfere with chondroitin sulphate (CS), complicating data interpretation of HS function. Herein, a simple method for the selective inhibition of HS biosynthesis is described. Using endogenous metabolic sugar pathways, Ac4GalNAz produces UDP-GlcNAz, which can target HS synthesis. Cell treatment with Ac4GalNAz resulted in defective chain elongation of the polymer and decreased HS expression. Conversely, no adverse effect on CS production was observed. The inhibition was transient and dose-dependent, affording rescue of HS expression after removal of the unnatural azido sugar. The utility of inhibition is demonstrated in cell culture and in whole organisms, demonstrating that this small molecule can be used as a tool for HS inhibition in biological systems.
dc.languageen
dc.publisherMDPI
dc.rightsLicence for this article: https://creativecommons.org/licenses/by/4.0/
dc.sourceeissn: 1422-0067
dc.subjectheparan sulfate
dc.subjectazido sugar
dc.subjectglycosaminoglycan
dc.subjectcarbohydrate biosynthesis
dc.subjectsmall molecule inhibitor
dc.subjectbiorthogonal chemistry
dc.titleSelective Inhibition of Heparan Sulphate and Not Chondroitin Sulphate Biosynthesis by a Small, Soluble Competitive Inhibitor
dc.typearticle
dc.date.updated2021-07-01T02:12:29Z
dc.date.accepted2021-06-19


Files in this item

Thumbnail
Name:
ijms-22-06988-v2.pdf
Size:
2.297Mb
Format:
PDF
Thumbnail
Name:
additional-files.zip
Size:
1.454Mb
Format:
Unknown
Thumbnail
Name:
ijms-22-06988.xml
Size:
9.586Kb
Format:
XML

This item appears in the following Collection(s)

Show simple item record